ResMed Inc. (NYSE:RMD) Q2 2023 Earnings Conference Call January 26, 2023 4:30 PM ET Company Participants Amy Wakeham - VP, IR & Corporate Communications Mick Farrell - CEO and Chairman Brett Sandercock - CFO Rob Douglas - President and COO Conference Call Participants Chris Cooper - Goldman Sachs Suraj Kalia - Oppenheimer Matthew Mishan - KeyBanc Capital Markets Steve Wheen - Jarden David Bailey - Macquarie Mike Matson - Needham & Company Craig Wong-Pan - RBC Sean Laaman - Morgan Stanley Margaret Kaczor - W ...

Three Months Ended Six Months Ended GAAP income from operations Amortization of acquired intangibles—cost of sales (A) Amortization of acquired intangibles—operating expenses (A) Amortization of acquired intangibles—operating expenses, net of tax (A) GAAP diluted shares outstanding (A) ResMed adjusts for the impact of the amortization of acquired intangibles, acquisition-related expenses, and the reserve for disputed tax positions from their evaluation of ongoing operations and believes that investors benef ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ______________________________________________________________________________________________ FORM 10-Q ______________________________________________________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 F ...

ResMed Inc. (NYSE:RMD) Q1 2023 Earnings Conference Call October 27, 2022 4:30 PM ET Company Participants Amy Wakeham - VP, IR & Corporate Communications Mick Farrell - CEO & Director Brett Sandercock - CFO Rob Douglas - President, COO and Interim President, Sleep & Respiratory Care David Pendarvis - Chief Administrative Officer and Global General Counsel Conference Call Participants Steve Wheen - Jarden Matt Mishan - KeyBanc Gretel Janu - Credit Suisse Saul Hadassin - Barrenjoey Capital Dan Hurren - MST Mar ...

Q1 FY2023 Earnings October 27, 2022 Presentation of financial information & forward-looking statements Historical financial and operating data in this presentation reflect the consolidated results of ResMed Inc., its subsidiaries, and its legal entities, for the periods indicated. This presentation includes financial information prepared in accordance with accounting principles generally accepted in the United States, or GAAP, as well as other financial measures referred to as non-GAAP. The non-GAAP financi ...

Resmed, Inc. (NYSE:RMD) Q4 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Amy Wakeham - VP, IR & Corporate Communications Michael Farrell - CEO & Director Brett Sandercock - CFO Robert Douglas - President, COO and Interim President, Sleep & Respiratory Care Conference Call Participants Craig Wong-Pan - RBC Capital Markets Sean Laaman - Morgan Stanley Margarate Boeye - William Blair & Company David Bailey - Macquarie Research Michael Matson - Needham & Company Lyanne Harrison - ...

Q4 FY2022 Earnings August 11, 2022 Presentation of financial information & forward-looking statements Historical financial and operating data in this presentation reflect the consolidated results of ResMed Inc., its subsidiaries, and its legal entities, for the periods indicated. This presentation includes financial information prepared in accordance with accounting principles generally accepted in the United States, or GAAP, as well as other financial measures referred to as non-GAAP. The non-GAAP financia ...

SECURITIES AND EXCHANGE COMMISSION UNITED STATES Commission file number: 001-15317 ___________________________________________________________________________________________ ResMed Inc. (Exact name of registrant as specified in its charter) ___________________________________________________________________________________________ Delaware (State or other jurisdiction of incorporation or organization) 98-0152841 (IRS Employer Identification No.) 9001 Spectrum Center Blvd. San Diego, CA 92123 United States ...

Acquisition of MEDIFOX DAN June 14, 2022 Forward-looking statements Historical financial and operating data in this presentation reflect the consolidated results of ResMed Inc., its subsidiaries, and its legal entities, for the periods indicated. This presentation includes financial information prepared in accordance with accounting principles generally accepted in the United States, or GAAP, as well as other financial measures referred to as non-GAAP. The non-GAAP financial measures in this presentation, w ...

Q3 FY2022 Earnings April 28, 2022 Presentation of financial information & forward-looking statements Historical financial and operating data in this presentation reflect the consolidated results of ResMed Inc., its subsidiaries, and its legal entities, for the periods indicated. This presentation includes financial information prepared in accordance with accounting principles generally accepted in the United States, or GAAP, as well as other financial measures referred to as non-GAAP. The non-GAAP financial ...